Mark Pruzanski
2014
In 2014, Mark Pruzanski earned a total compensation of $3.2M as Chief Executive Officer and President at Intercept Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Bonus | $327,250 |
|---|---|
| Option Awards | $1,108,935 |
| Salary | $537,500 |
| Stock Awards | $1,249,981 |
| Other | $4,444 |
| Total | $3,228,110 |
Pruzanski received $1.2M in stock awards, accounting for 39% of the total pay in 2014.
Pruzanski also received $327.3K in bonus, $1.1M in option awards, $537.5K in salary and $4.4K in other compensation.
Rankings
In 2014, Mark Pruzanski's compensation ranked 2,789th out of 13,032 executives tracked by ExecPay. In other words, Pruzanski earned more than 78.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,789 out of 13,032 | 79th |
Division Manufacturing | 989 out of 4,966 | 80th |
Major group Chemicals And Allied Products | 315 out of 1,686 | 81st |
Industry group Drugs | 245 out of 1,365 | 82nd |
Industry Pharmaceutical Preparations | 202 out of 1,043 | 81st |
Source: SEC filing on June 20, 2016.
Pruzanski's colleagues
We found four more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2014.